Lv1
50 积分 2026-05-23 加入
Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis
1个月前
已完结
Addressing Unmet Needs in Atopic Dermatitis: Evaluating Disease-Modifying Capabilities of Current and Emerging Therapies
1个月前
已完结
Abrocitinib Treatment Modes: Impact on Prognosis and Relapse Rates in Atopic Dermatitis
1个月前
已关闭
Efficacy, Safety, and Early Relapse after Cessation of Upadacitinib versus Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis®: A Real-World Study in China
1个月前
已完结
Atopic dermatitis relapse after treatment discontinuation and predictive factors for relapse: JAK1 inhibitors versus dupilumab
1个月前
已完结
The real‐world, long‐term risk of infections associated with dupilumab in atopic dermatitis: A global cohort study
1个月前
已完结
Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study
1个月前
已完结
Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis
1个月前
已完结
皖公网安备34019202002308
